Skip to main content

Trond Aasen

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Trond Aasen

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Matilde Lleonart Pajarin, Cleofé Romagosa Pérez-Portabell, Teresa Moline Marimon, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Antima Martinez Saez, Javier Hernandez Losa, Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 631500.61
Reference: RD06/0020/0104
Duration: 02/01/2007 - 31/12/2014

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

Related professionals

Ariel Cañón Pérez

Ariel Cañón Pérez

Tècnic/a Superior Recerca
Experimental Surgery Unit (ESU)
Preclinical Core Facilities
Core Facilities Area
Read more
Sandra Diez Ribas

Sandra Diez Ribas

Administration and Management
Read more
Edgar Verdura Peralta

Edgar Verdura Peralta

Postdoctoral researcher
Pediatric Neurology
Read more
Joan Roig Soriano

Joan Roig Soriano

Postdoctoral researcher
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.